Paper39489491
Melanoma Diagnosis in the Mihm Era-And Beyond.
Elder DE. J Cutan Pathol, 2026. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Melanoma Diagnosis in the Mihm Era-And Beyond. Papers, record 39489491. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39489491
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Melanoma | Major topic |
| Skin Neoplasms | Major topic |
| Humans | |
| History, 20th Century | |
| Overdiagnosis | |
| History, 21st Century |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39026390 | Estimating the magnitude and healthcare costs of melanoma in situ and thin invasive melanoma overdiagnosis in Australia. | Br J Dermatol | 2024 | https://conductscience.org/library/papers/39026390 | PubMed |
| 2 | 29367314 | Overdiagnosis: what it is and what it isn't. | BMJ Evid Based Med | 2018 | https://conductscience.org/library/papers/29367314 | PubMed |
| 3 | 602975 | Plantar lentiginous melanoma: a distinctive variant of human cutaneous malignant melanoma. | Am J Surg Pathol | 1977 | https://conductscience.org/library/papers/602975 | PubMed |
| 4 | 29141225 | A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma. | Cell Rep | 2017 | https://conductscience.org/library/papers/29141225 | PubMed |
| 5 | 1468256 | Risk classification of life and health insurance applicants with atypical melanocytic hyperplasia or malignant melanoma in situ. | Cutis | 1992 | https://conductscience.org/library/papers/1468256 | PubMed |
| 6 | 28659278 | Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study. | BMJ | 2017 | https://conductscience.org/library/papers/28659278 | PubMed |
| 7 | 6500548 | A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. | Hum Pathol | 1984 | https://conductscience.org/library/papers/6500548 | PubMed |
| 8 | 4053039 | Characteristics of cultured human melanocytes isolated from different stages of tumor progression. | Cancer Res | 1985 | https://conductscience.org/library/papers/4053039 | PubMed |
| 9 | 6528943 | Invasive malignant melanomas lacking competence for metastasis. | Am J Dermatopathol | 1984 | https://conductscience.org/library/papers/6528943 | PubMed |
| 10 | 37938821 | Pathologist Characteristics Associated With Rendering Higher-Grade Diagnoses for Melanocytic Lesions. | JAMA Dermatol | 2023 | https://conductscience.org/library/papers/37938821 | PubMed |
| 11 | 30045064 | PRAME Expression in Melanocytic Tumors. | Am J Surg Pathol | 2018 | https://conductscience.org/library/papers/30045064 | PubMed |
| 12 | 790575 | The developmental biology of primary human malignant melanomas. | Semin Oncol | 1975 | https://conductscience.org/library/papers/790575 | PubMed |
| 13 | 3980788 | No one should die of malignant melanoma. | J Am Acad Dermatol | 1985 | https://conductscience.org/library/papers/3980788 | PubMed |
| 14 | 36642569 | Diagnostic error, uncertainty, and overdiagnosis in melanoma. | Pathology | 2023 | https://conductscience.org/library/papers/36642569 | PubMed |
| 15 | 21497295 | Copy number gains in 11q13 and 8q24 [corrected] are highly linked to prognosis in cutaneous malignant melanoma. | J Mol Diagn | 2011 | https://conductscience.org/library/papers/21497295 | PubMed |
| 16 | 20413742 | Overdiagnosis in cancer. | J Natl Cancer Inst | 2010 | https://conductscience.org/library/papers/20413742 | PubMed |
| 17 | 36336975 | Prognostic modeling of cutaneous melanoma stage I patients using cancer registry data identifies subsets with very-low melanoma mortality. | Cancer | 2023 | https://conductscience.org/library/papers/36336975 | PubMed |
| 18 | 24910143 | Prognostic factors in localized invasive primary cutaneous malignant melanoma: results of a large population-based study. | Br J Dermatol | 2015 | https://conductscience.org/library/papers/24910143 | PubMed |
| 19 | 29579032 | Vertical Growth Phase as a Prognostic Factor for Sentinel Lymph Node Positivity in Thin Melanomas: A Systematic Review and Meta-Analysis. | Plast Reconstr Surg | 2018 | https://conductscience.org/library/papers/29579032 | PubMed |
| 20 | 10333228 | Progression-related expression of beta3 integrin in melanomas and nevi. | Hum Pathol | 1999 | https://conductscience.org/library/papers/10333228 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 39489491 | Melanoma Diagnosis in the Mihm Era-And Beyond. | J Cutan Pathol | 2026 | https://conductscience.org/library/papers/39489491 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39489491
GET https://conductscience.org/api/papers/v1/39489491/references?page=2